Back to dataset
Inflammatory bowel disease national clinical audit of biological therapies (2015)Paediatric biological therapies data - IBD audit 2015
You're previewing the first 4 rows of this file.
Download this fileHealth board / Trust name | Sitename | Participation status | Crohns disease patients time from diagnosis to initial treatment, years, Median (IQR) | Initial treatment PCDAI score, Median (IQR) | Crohns disease patients remission achieved | Crohns disease patients on concomitant immunosuppression at start of treatment | Crohns disease patients with adverse event recorded at 3 month follow-up | Crohns disease patients PROMs completed at start of treatment |
---|---|---|---|---|---|---|---|---|
Alder Hey Childrens NHS Foundation Trust | Alder Hey Childrens Hospital | Participant | n=61, 1 (1, 3) | n=52, 25 (12, 32) | 23/32 (72%) | 59/61 (97%) | 1/34 (3%) | 43/61 (71%) |
Barts Health NHS Trust | Barts and The London Childrens Hospital* | Participant | n=32, 2 (1, 3) | n=0 | n=0 | 18/21 (86%) | (n<6 | 10/32 (31%) |
Birmingham Childrens Hospital NHS Foundation Trust | Birmingham Childrens Hospital | Participant | n=64, 1 (0, 2) | n=17, 15 (5, 32) | n<6 | 51/65 (79%) | 4/49 (8%) | 0/65 (0%) |
Brighton and Sussex University Hospitals NHS Trust | The Royal Alexandra Childrens Hospital* | Participant | n=6, 4 (2, 7) | n=6, 26 (11, 35) | n<6 | (n=0 | (n<6 | 5/6 (83%) |